In line with these findings, inhibitors of LDH and MCT, which regulate aerobic glycolytic metabolism, have been found to have potential as radiosensitizers in models of glioblastoma, pancreatic, lung, and cervical cancer (Yang et al., 2020; Koukourakis et al., 2017; Bola et al., 2014; Corbet et al., 2018). Here, SLC16A1 is linked to glioblastoma.